Division of Infectious Diseases
Saint Louis University School of Medicine's Division of Infectious Diseases provides clinical instruction, consultation and research. It's well known internationally for its significant contributions to vaccine development.
Preventing and Treating Infectious Diseases
The Division of Infectious Diseases is renowned for its leadership in clinical care and research. Faculty work in both hospitals and outpatient clinics to treat, manage and prevent complex infectious diseases, and they are experts in clinical hospital epidemiology and clinical microbiology.
The division heads the Center for Vaccine Development, one of 10 Vaccine and Treatment Evaluation Units (VTEU) funded by the National Institute of Health, and the University's VTEU is one of only two designated sites to conduct comprehensive omics assessments for vaccines and therapies. The center has developed and tested vaccines and pathogenic and pandemic viruses such as influenza, tuberculosis, flaviviruses, COVID-19 and hepatitis C. It is known for its rapid responses during public health crises.
Infectious Diseases Research and Education
The division offers robust fellowship training in infectious diseases and has a strong program in bacterial and viral vaccine research, as well as in basic virology and immunology. Graduate medical students can combine their clinical training with research training in microbiology, biochemistry and molecular biology or cell and molecular biology.
A biosafety level-3 laboratory provides opportunities for TB and AIDS-related research.
Research Areas
- Vaccine development and evaluation
- Respiratory virus
- Bacterial conjugate
- Rotavirus
- BCG
- HIV-1
- Epidemiology and basic research
- Influenza A
- Hepatitis C
- Pertussis